Search results for: Adrian Towse
Filter search results
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…to develop better technologies that deliver more health and economic gain. Chalkidou, K., Towse, A., Silverman, R., Garau, M., & Ramakrishnan, G. (2020). Market-driven, value-based, advance commitment (MVAC): accelerating the…
The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis
30 June 2022
…value of a novel orphan medicine. Related research Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Garau,…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
…of co-dependent technologies. A revised version of this paper has been published in Personalized Medicine and can be downloaded from: https://www.futuremedicine.com/doi/abs/10.2217/pme.12.99 Please cite as: Garau, M., Towse, A., Garrison, L.,…
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
…has been published in PharmacoEconomics and can be downloaded from: https://link.springer.com/article/10.1007%2Fs40273-012-0001-x Please cite as: Sussex, J., Towse, A. and Devlin, N., 2013. Operationalizing value-based pricing of medicines. PharmacoEconomics, 31(1), pp.1-10….
Incentives for R&D for New Antimicrobial Drugs
1 April 2011
…and can be downloaded from: https://www.tandfonline.com/doi/abs/10.1080/13571516.2011.584434 Please cite as: Towse, A. and Sharma, P., 2011. Incentives for R&D for new antimicrobial drugs. International Journal of the Economics of Business, 18(2),…
Using QALYs in Cancer: Review of the Methodological Limitations
1 October 2010
…and can be downloaded from: https://link.springer.com/article/10.2165%2F11588250-000000000-00000 Please cite as: Garau, M., Shah, K.K., Mason, A.R., Wang, Q., Towse, A. and Drummond, M.F., 2011. Using QALYs in cancer. Pharmacoeconomics, 29(8), pp.673-685….
The Future of Primary Care
1 January 1996
…of and solutions to low GP morale, by Professor Mant and Mr Towse. In the final chapter, Professor Roland sets out his vision as to how the dangers of fragmentation…
Improving Efficiency and Resource Allocation in Future Cancer Care
9 January 2016
…M., Welin, K-O., Bianchi, S., Althin, R., O’Neill, P., Persson, U., and Towse, A. (2016) Improving Efficiency and Resource Allocation in Future Cancer Care. OHE Contract Research. Available from https://www.ohe.org/publications/improving-efficiency-and-resource-allocation-future-cancer-care/…
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…